Rafarma Pharmaceuticals constructed and now operates a 270,000-square foot multi-purpose pharmaceutical facility in Russia in direct response to the Russian Government’s plan to significantly advance the domestic pharmaceutical industry in the Russian Federation.
In a recent video interview with the QualityStocks Production team, Rafarma CEO Sergey Brunsnitsyn details the operations and qualification of the production plant, how it meets world standards in the field of pharmaceuticals and industrial construction, and the company’s strategy to secure 5 percent of market share in the Russian pharmaceuticals market by 2017.
“The strategies of the company, the professional team, the modern production facilities and our projects allow us to look forward with confidence and ensure the presence of high-quality generics and innovative medical products for our Russian and foreign consumers,” Brunsnitsyn says in the interview.
To view the entire video production visit http://videos.qualitystocks.net
For more information visit www.rafarma.com
About QualityStocks
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. We offer several ways for investors to find, evaluate, and learn more about investing in these companies.
Sign up for “The QualityStocks Daily Newsletter” at www.QualityStocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks Daily Videos http://videocharts.qualitystocks.net
The Quality Stocks “Ones to Watch” http://gotstocks.qualitystocks.net
Please see disclaimer on the QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment